Clinical Trial Update: SPECT-CT Guided Lymphatic Mapping and Sentinel Lymphadenectomy (LM/SL) in Prostate Cancer [NA]

View source ↗

Summary

This clinical trial update documents termination of a study evaluating SPECT-CT guided lymphatic mapping and sentinel lymphadenectomy for prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Prostate Cancer | NA | Status: TERMINATED